Clinical Trial Update: Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fluorescence detection of adult primary central nervous system tumors using Tozuleristide with the Canvas System has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumor

Drugs mentioned

• Canvas System
• Tozuleristide (tozuleristide)

Snippet

Sponsor: John Yu | Conditions: Central Nervous System Tumor | Phase 2 | Status: COMPLETED